160 related articles for article (PubMed ID: 38543175)
1. Cytotoxic and Antiproliferative Activity of LASSBio-2208 and the Attempts to Determine Its Drug Metabolism and Pharmacokinetics In Vitro Profile.
Pillpe-Meza RM; Gouveia WL; Barbosa G; Fraga CAM; Barreiro EJ; Lima LM
Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543175
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis and Phenotypic Profiling of Simplified Gedatolisib Analogues.
Costa CMX; Aparecida-Silva C; Gamba LER; de Melo TN; Barbosa G; Moraes Junior MO; de Oliveira VRT; de Amorim CS; Moraes JA; Barreiro EJ; Lima LM
Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259357
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis and Biological Evaluation of Novel N-hydroxyheptanamides Incorporating 6-hydroxy-2-methylquinazolin-4(3H)-ones as Histone Deacetylase Inhibitors and Cytotoxic Agents.
Minh NV; Thanh NT; Lien HT; Anh DTP; Cuong HD; Nam NH; Hai PT; Minh-Ngoc L; Le-Thi-Thu H; Chinh LV; Vu TK
Anticancer Agents Med Chem; 2019; 19(12):1543-1557. PubMed ID: 31267876
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic Profile Evaluation of Novel Combretastatin Derivative, LASSBio-1920, as a Promising Colorectal Anticancer Agent.
Guimarães CJ; Carneiro TR; Frederico MJS; de Carvalho GGC; Little M; Freire VN; França VLB; do Amaral DN; Guedes JS; Barreiro EJ; Lima LM; Barros-Nepomuceno FWA; Pessoa C
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111767
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Small-Molecule HDAC Inhibitors Through In Vitro and In Cellulo Approaches.
Nawar N; Garcha HK; Sedighi A; de Araujo ED; Gunning PT
Methods Mol Biol; 2023; 2589():157-177. PubMed ID: 36255624
[TBL] [Abstract][Full Text] [Related]
6. Biochemical, biological and structural properties of romidepsin (FK228) and its analogs as novel HDAC/PI3K dual inhibitors.
Saijo K; Imamura J; Narita K; Oda A; Shimodaira H; Katoh T; Ishioka C
Cancer Sci; 2015 Feb; 106(2):208-15. PubMed ID: 25492515
[TBL] [Abstract][Full Text] [Related]
7. Discovery of benzamide-based PI3K/HDAC dual inhibitors with marked pro-apoptosis activity in lymphoma cells.
Deng J; Hou B; Hou X; Chen Y; Zhang T; Chen H; Wang Y; Li X
Eur J Med Chem; 2023 Dec; 262():115915. PubMed ID: 37948955
[TBL] [Abstract][Full Text] [Related]
8. Romidepsin (FK228) and its analogs directly inhibit phosphatidylinositol 3-kinase activity and potently induce apoptosis as histone deacetylase/phosphatidylinositol 3-kinase dual inhibitors.
Saijo K; Katoh T; Shimodaira H; Oda A; Takahashi O; Ishioka C
Cancer Sci; 2012 Nov; 103(11):1994-2001. PubMed ID: 22924958
[TBL] [Abstract][Full Text] [Related]
9. The synergism of 6-mercaptopurine plus cytosine arabinoside followed by PEG-asparaginase in human leukemia cell lines (CCRF/CEM/0 and (CCRF/CEM/ara-C/7A) is due to increased cellular apoptosis.
Nandy P; Periclou AP; Avramis VI
Anticancer Res; 1998; 18(2A):727-37. PubMed ID: 9615712
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity and pharmacologic characterization of the depsipeptide analog as a novel histone deacetylase/ phosphatidylinositol 3-kinase dual inhibitor.
Saijo K; Imai H; Chikamatsu S; Narita K; Katoh T; Ishioka C
Cancer Sci; 2017 Jul; 108(7):1469-1475. PubMed ID: 28406576
[TBL] [Abstract][Full Text] [Related]
11. Structural optimization of tetrahydroisoquinoline-hydroxamate hybrids as potent dual ERα degraders and HDAC inhibitors.
Xiong S; Wang X; Zhu M; Song K; Li Y; Yang J; Liu X; Liu M; Dong H; Chen M; Chen D; Xiang H; Luo G
Bioorg Chem; 2023 May; 134():106459. PubMed ID: 36924653
[TBL] [Abstract][Full Text] [Related]
12. 8,8-bis-(Dihydroconiferyl)-diferulate displayed impressive cytotoxicity towards a panel of human and animal cancer cells.
Mbaveng AT; Damen F; Guefack MF; Tankeo SB; Abdelfatah S; Bitchagno GTM; Çelik İ; Kuete V; Efferth T
Phytomedicine; 2020 Apr; 70():153215. PubMed ID: 32388040
[TBL] [Abstract][Full Text] [Related]
13. Novel Single Inhibitor of HDAC6/8 and Dual Inhibitor of PI3K/HDAC6 as Potential Alternative Treatments for Prostate Cancer.
Guerra FS; Rodrigues DA; Fraga CAM; Fernandes PD
Pharmaceuticals (Basel); 2021 Apr; 14(5):. PubMed ID: 33919077
[TBL] [Abstract][Full Text] [Related]
14. Methyl Effect on the Metabolism, Chemical Stability, and Permeability Profile of Bioactive
Guedes JS; Carneiro TR; Pinheiro PSM; Fraga CAM; Sant Anna CMR; Barreiro EJ; Lima LM
ACS Omega; 2022 Nov; 7(43):38752-38765. PubMed ID: 36340078
[TBL] [Abstract][Full Text] [Related]
15. Discovery of FNDR-20123, a histone deacetylase inhibitor for the treatment of Plasmodium falciparum malaria.
Potluri V; Shandil RK; Gavara R; Sambasivam G; Campo B; Wittlin S; Narayanan S
Malar J; 2020 Oct; 19(1):365. PubMed ID: 33046062
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic compounds from the fruits of Uapaca togoensis towards multifactorial drug-resistant cancer cells.
Kuete V; Sandjo LP; Seukep JA; Zeino M; Mbaveng AT; Ngadjui B; Efferth T
Planta Med; 2015 Jan; 81(1):32-8. PubMed ID: 25473921
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity of trimetrexate against antifolate-resistant human T-cell leukemia cell lines developed in oxidized or reduced folate.
Miyachi H; Takemura Y; Kobayashi H; Ando Y
Jpn J Cancer Res; 1997 Sep; 88(9):900-6. PubMed ID: 9369939
[TBL] [Abstract][Full Text] [Related]
18. Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines.
Sixto-López Y; Gómez-Vidal JA; de Pedro N; Bello M; Rosales-Hernández MC; Correa-Basurto J
Sci Rep; 2020 Jun; 10(1):10462. PubMed ID: 32591593
[TBL] [Abstract][Full Text] [Related]
19. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
Avramis IA; Laug WE; Sausville EA; Avramis VI
Cancer Chemother Pharmacol; 2003 Oct; 52(4):307-18. PubMed ID: 12827297
[TBL] [Abstract][Full Text] [Related]
20. Tackling the Cytotoxic Effect of a Marine Polycyclic Quinone-Type Metabolite: Halenaquinone Induces Molt 4 Cells Apoptosis via Oxidative Stress Combined with the Inhibition of HDAC and Topoisomerase Activities.
Shih SP; Lee MG; El-Shazly M; Juan YS; Wen ZH; Du YC; Su JH; Sung PJ; Chen YC; Yang JC; Wu YC; Lu MC
Mar Drugs; 2015 May; 13(5):3132-53. PubMed ID: 26006712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
